Your browser doesn't support javascript.
loading
FcyRIIB is a novel immune checkpoint in the tumor microenvironment limiting activity of Treg-targeting antibodies.
Knorr, David; Leidner, Rom; Jensen, Shawn; Meng, Ryan; Jones, Andrew; Ballesteros-Merino, Carmen; Bell, R Bryan; Baez, Maria; Sprott, David; Bifulco, Carlo; Piening, Brian; Dahan, Rony; Fox, Bernard A; Ravetch, Jeffrey.
Afiliação
  • Knorr D; Laboratory of Molecular Genetics and Immunology, Rockefeller University, New York, NY.
  • Leidner R; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Jensen S; Earle A. Chiles Research Institute, a division of Providence Cancer Institute, Portland, OR.
  • Meng R; Earle A. Chiles Research Institute, a division of Providence Cancer Institute, Portland, OR.
  • Jones A; Earle A. Chiles Research Institute, a division of Providence Cancer Institute, Portland, OR.
  • Ballesteros-Merino C; Laboratory of Molecular Genetics and Immunology, Rockefeller University, New York, NY.
  • Bell RB; Earle A. Chiles Research Institute, a division of Providence Cancer Institute, Portland, OR.
  • Baez M; Earle A. Chiles Research Institute, a division of Providence Cancer Institute, Portland, OR.
  • Sprott D; Laboratory of Molecular Genetics and Immunology, Rockefeller University, New York, NY.
  • Bifulco C; Earle A. Chiles Research Institute, a division of Providence Cancer Institute, Portland, OR.
  • Piening B; Earle A. Chiles Research Institute, a division of Providence Cancer Institute, Portland, OR.
  • Dahan R; Earle A. Chiles Research Institute, a division of Providence Cancer Institute, Portland, OR.
  • Fox BA; Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.
  • Ravetch J; Earle A. Chiles Research Institute, a division of Providence Cancer Institute, Portland, OR.
bioRxiv ; 2023 Jan 20.
Article em En | MEDLINE | ID: mdl-36711504

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article